Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
Le dernier exercice comptable publié pour cette entreprise remonte à 2022. Les données ci-dessous peuvent ne plus refléter sa situation actuelle.
PHARMASUD : revenue, balance sheet and financial ratios
PHARMASUD is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PORTO-VECCHIO (20137),
this company of category PME
shows in 2022 a net income positive of 970 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-08-01
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
Synthèse
Santé financière :
Saine
Aucun signal de fragilité majeur : rentabilité positive et structure financière équilibrée.
In summary, PHARMASUD posts positive profitability over the latest financial year. Its financial structure is solid, with debt well contained relative to its sector.
Revenue and income statement
In 2022, PHARMASUD generates positive net income of 970 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2022: 59 k€ -> 970 k€.
Net income (2022)
?
970 346 €
Loading income statement...
The detailed income statement is not available for this company (simplified accounts or confidential data).
Assets
Loading data...
Assets balance sheet data not available for this company
Liabilities
Loading data...
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 45%. This ratio is more favorable than the sector median (76.9%). Financial autonomy (= Equity / Total assets x 100) reaches 54%. This ratio is more favorable than the sector median (46.5%).
Debt ratio (2022)
?
45.03%
Financial autonomy (2022)
?
54.41%
Asset age ratio (2022)
?
37.8%
| Indicator |
2015 |
2016 |
2017 |
2019 |
2020 |
2022 |
| Debt ratio |
15.07 |
6.345 |
3.33 |
142.957 |
114.297 |
45.031 |
| Financial autonomy |
55.762 |
56.55 |
74.119 |
31.082 |
35.037 |
54.408 |
| Repayment capacity |
None |
None |
None |
None |
None |
None |
| Cash flow / Revenue |
None% |
None% |
None% |
None% |
None% |
None% |
Sector positioning
Q1: 25.28%
Med: 76.93%
Q3: 189.84%
Good
-26 pts over 3 years
In 2022, the debt ratio of PHARMASUD (45.0%) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Q1: 28.18%
Med: 46.54%
Q3: 65.98%
Good
+27 pts over 3 years
In 2022, the financial autonomy of PHARMASUD (54.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 3.50. Compared with its sector, this ratio places the company among the best positioned (sector median: 2.0).
Liquidity ratio (2022)
?
3.5
| Indicator |
2015 |
2016 |
2017 |
2019 |
2020 |
2022 |
| Liquidity ratio |
1.15356 |
1.31857 |
1.84305 |
2.15578 |
2.48786 |
3.4968 |
| Interest coverage |
None |
None |
None |
None |
None |
None |
Sector positioning
Q1: 1.48
Med: 2.03
Q3: 2.75
Excellent
In 2022, the liquidity ratio of PHARMASUD (3.50) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMASUD in its sector
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMASUD is estimated at
11 417 584 €
(range 7 674 885€ - 17 124 256€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
11 417 584 €
Range: 7 674 885€ - 17 124 256€
NAF 5 année 2022
Valuation method used
Net Income Multiple
970 346 €
×
11.8x
=
11 417 585 €
Range: 7 674 885€ - 17 124 257€
Only this financial indicator is available for this company.
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
- EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
- Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
- Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Top companies in Commerce de détail de produits pharmaceutiques en magasin spécialisé
Largest companies by revenue in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé:
Top companies in 20
Largest companies by revenue in the department 20:
Frequently asked questions about PHARMASUD
What is the revenue of PHARMASUD ?
The revenue of PHARMASUD is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMASUD profitable?
Yes, PHARMASUD generated a net profit of 970 k€ in 2022.
Where is the headquarters of PHARMASUD ?
The headquarters of PHARMASUD is located in PORTO-VECCHIO (20137).
Where to find the tax return of PHARMASUD ?
The tax return of PHARMASUD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMASUD operate?
PHARMASUD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.